Price
$154.49
Decreased by -1.43%
Dollar Volume
230.54 M
ADR%
1.89
Earnings Report Date (estimate)
Feb 1, 23 (2.63)
Market Cap.
31.22 B
Shares Float
170.66 M
Shares Outstanding
202.08 M
Beta
0.54
Price / Earnings
19.22
BPR
62.49
20D Range
154.19 169.16
50D Range
154.19 174.63
200D Range
134.72 174.63
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Feb 1, 23 2.71
Increased by +5.04%
2.64
Increased by +2.65%
Nov 3, 22 2.60
Increased by +8.79%
2.57
Increased by +1.17%
Aug 3, 22 2.62
Increased by +21.30%
2.56
Increased by +2.34%
May 4, 22 3.22
Increased by +27.27%
2.93
Increased by +9.90%
Feb 2, 22 2.58
Increased by +18.35%
2.57
Increased by +0.39%
Nov 4, 21 2.39
Increased by +26.46%
2.36
Increased by +1.27%
Aug 4, 21 2.16
Increased by +16.76%
2.05
Increased by +5.37%
May 5, 21 2.53
Increased by +5.42%
2.48
Increased by +2.02%
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 22 61.17 B
Increased by +3.84%
294.74 M
Decreased by -32.66%
Increased by +0.48%
Decreased by -35.15%
Jun 30, 22 60.06 B
Increased by +12.47%
406.96 M
Increased by +39.31%
Increased by +0.68%
Increased by +23.87%
Mar 31, 22 57.72 B
Increased by +17.43%
548.01 M
Increased by +25.90%
Increased by +0.95%
Increased by +7.22%
Dec 31, 21 59.63 B
Increased by +13.54%
449.11 M
Increased by +19.81%
Increased by +0.75%
Increased by +5.52%
Sep 30, 21 58.91 B
Increased by +19.63%
437.70 M
Increased by +109.03%
Increased by +0.74%
Increased by +107.55%
Jun 30, 21 53.41 B
Increased by +17.72%
292.12 M
Increased by +0.93%
Increased by +0.55%
Decreased by -14.27%
Mar 31, 21 49.15 B
Increased by +3.66%
435.27 M
Decreased by -54.67%
Increased by +0.89%
Decreased by -56.27%
Dec 31, 20 52.52 B
Increased by +9.72%
374.85 M
Increased by +99.77%
Increased by +0.71%
Increased by +82.07%
  • Top 20 ETF Stock Exposure
  • Top 20 Institutional Holders
  • Top 20 Mutual Fund Holders
Rank ETF Shares Market Value Weight % in ETF
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

AmerisourceBergen Corporation sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturer. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segments also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.